Your browser doesn't support javascript.
loading
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation.
Watts, Gerald F; Gidding, Samuel; Wierzbicki, Anthony S; Toth, Peter P; Alonso, Rodrigo; Brown, W Virgil; Bruckert, Eric; Defesche, Joep; Lin, Khoo Kah; Livingston, Michael; Mata, Pedro; Parhofer, Klaus G; Raal, Frederick J; Santos, Raul D; Sijbrands, Eric J G; Simpson, William G; Sullivan, David R; Susekov, Andrey V; Tomlinson, Brian; Wiegman, Albert; Yamashita, Shizuya; Kastelein, John J P.
Afiliação
  • Watts GF; Cardiometabolic Service, Department of Internal Medicine, Royal Perth Hospital, School of Medicine and Pharmacology, The University of Western Australia, GPO Box X2213, Perth, WA 6847, Australia. Electronic address: gerald.watts@uwa.edu.au.
  • Gidding S; Cardiology Division, Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, DE, USA; Jefferson Medical College, Philadelphia, PA, USA.
  • Wierzbicki AS; Department of Metabolic Medicine and Chemical Pathology, Guy's & St Thomas Hospitals, NHS Foundation Trust, London, UK.
  • Toth PP; CGH Medical Centre, Sterling, IL, USA; University of Illinois College of Medicine, Peoria, IL, USA; Illinois Michigan State University College of Osteopathic Medicine, East Lansing, MI, USA.
  • Alonso R; Lipid Clinic, Department of Internal Medicine, Fundacion Jimenez Diaz, Madrid, Spain.
  • Brown WV; Emory University School of Medicine, Emory University, Atlanta, GA, USA.
  • Bruckert E; Department of Endocrinology and Prevention of Cardiovascular Disease, Hôpital Pitié-Salpêtrière, University of Paris VI, Paris, France.
  • Defesche J; Laboratory for Experimental Vascular Medicine, Section of Molecular Diagnostics, Academic Medical Centre, University of Amsterdam, The Netherlands.
  • Lin KK; Pontai Medical Centre, Heart Foundation of Malaysia, Kuala Lumpur, Malaysia.
  • Livingston M; The International FH Foundation, St Andrews Court, Thame, Oxfordshire, UK.
  • Mata P; Fundacion Hipercolesterolemia Familiar, Madrid, Spain.
  • Parhofer KG; Medical Department 2, Division of Metabolism and Endocrinology, Ludwig- Maximilians-University of Munich, Munich, Germany.
  • Raal FJ; Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Santos RD; Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School, University of Sao Paulo, Sao Paulo, Brazil.
  • Sijbrands EJ; Section of Pharmacology, Vascular and Metabolic Diseases, Department of Internal Medicine, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands.
  • Simpson WG; Department of Clinical Biochemistry, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, Scotland.
  • Sullivan DR; Lipid Clinic and Department of Biochemistry, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Susekov AV; Laboratory of Clinical Lipidology, Department of Atherosclerosis, Cardiology Research Complex, Ministry of Health of Russian Federation, Moscow, Russia.
  • Tomlinson B; Division of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, The People's Republic of China.
  • Wiegman A; Department of Paediatrics, Academic Medical Centre, University of Amsterdam, The Netherlands.
  • Yamashita S; Department of Community Medicine and Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka University, Japan.
  • Kastelein JJ; Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands.
J Clin Lipidol ; 8(2): 148-72, 2014.
Article em En | MEDLINE | ID: mdl-24636175

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperlipoproteinemia Tipo II / Lipoproteínas LDL / LDL-Colesterol Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: J Clin Lipidol Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperlipoproteinemia Tipo II / Lipoproteínas LDL / LDL-Colesterol Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: J Clin Lipidol Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2014 Tipo de documento: Article